Correct usage and dosage of Acemini Lao version

Aximinib is a kinase inhibitor. Its principle of action is to inhibit the tyrosine kinase activity of BCR-ABL fusion protein by specifically binding toABL1 myristoyl pocket (STAMP). This binding method is highly specific and can block abnormal signaling pathways within leukemia cells, thereby inhibiting the proliferation and survival of tumor cells. This mechanism of action of acemini makes it excellent in the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), providing patients with a new treatment option. Proper usage and dosage are crucial when using Acemini Laos.

For patients with newly diagnosed or previously treated Ph+ CML-CP, the recommended dose of the Lao version of aceminib is 80 mg orally once daily at approximately the same time each day, or 40 mg orally twice daily, approximately 12 hours apart. It should be noted that the recommended dose of aximini should be taken orally without food, that is, food should be avoided within 2 hours before and 1 hour after taking it.

For Ph+ CML-CP patients carryingT315I mutation, the recommended dose of the Lao version of aceminib is different. Such patients need to take 200 mg orally twice daily, approximately 12 hours apart. Likewise, the drug should be taken without food, i.e. food should be avoided within 2 hours before and 1 hour after taking it.

During the medication process, if the patient accidentally misses a dose, corresponding treatment should be made according to the specific dosage plan. For a once-daily dosing regimen, if a dose is missed by more than approximately 12 hours, the dose should be skipped and the next dose should be taken as scheduled; for a twice-daily dosing regimen, if a dose is missed by more than approximately 6 hours, the dose should be skipped and the next dose should be taken as scheduled. This treatment principle is designed to ensure that patients can maintain a stable medication rhythm and avoid drastic fluctuations in drug concentrations.

In addition, while taking the Lao version of Assimini, patients should strictly abide by the doctor's instructions and do not change the dosage or stop taking the medicine on their own. Tablets should be swallowed whole and should not be broken, crushed or chewed as this may affect drug release and absorption. At the same time, patients should pay close attention to their body's reaction, and if they have any uncomfortable symptoms or side effects, they should contact their attending doctor immediately. The doctor may adjust the dose or temporarily or permanently discontinue treatment based on the patient's specific condition.

In summary, the correct use and dosage of Acemini Lao Edition are crucial to ensure therapeutic effectiveness. Patients should strictly follow the doctor's instructions and medication guidelines to ensure the accuracy and safety of medication. At the same time, maintain close communication with the doctor and provide timely feedback on the body's reaction so that the doctor can make appropriate adjustments based on the actual situation.

References:

https://www.drugs.com/pro/scemblix.html#s-34090-1